Diversified Healthcare Trust (DHC) Declares $0.01 Quarterly Dividend with 0.75% Yield
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Source: seekingalpha
- Dividend Declaration: Diversified Healthcare Trust (DHC) has declared a quarterly dividend of $0.01 per share, consistent with previous distributions, indicating the company's ongoing ability to maintain stable cash flows.
- Yield Information: The forward yield of this dividend stands at 0.75%, reflecting the company's shareholder return strategy in the current market environment, aimed at attracting long-term investors.
- Payment Schedule: The dividend is set to be paid on February 19, with a record date of January 26 and an ex-dividend date also on January 26, ensuring shareholders receive their earnings promptly.
- Market Response: DHC's dividend policy, combined with its positive outlook in the senior housing market, may enhance investor confidence and contribute to stock price stability.
Analyst Views on DHC
Wall Street analysts forecast DHC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for DHC is 3.75 USD with a low forecast of 3.00 USD and a high forecast of 4.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
1 Buy
1 Hold
1 Sell
Hold
Current: 5.500
Low
3.00
Averages
3.75
High
4.50
Current: 5.500
Low
3.00
Averages
3.75
High
4.50
About DHC
Diversified Healthcare Trust is a real estate investment trust (REIT). The Company is focused on owning healthcare properties located throughout the United States. It has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The Company's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
